Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia

Fabio Giuseppe Liberante, Tara Pouryahya, Mary Frances McMullin, Shu Dong Zhang, Kenneth Ian Mills

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)
55 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science